Neuberger Berman Group LLC Sells 44,394 Shares of UiPath, Inc. (NYSE:PATH)

Key Points

• Neuberger Berman Group LLC reduced its holdings in UiPath, Inc. by 1.8%, selling 44,394 shares and ending the quarter with 2,481,954 shares valued at approximately $25.6 million.
• Insider trading revealed that CEO Daniel Dines sold nearly 10,000 shares for $119,856, lowering his personal stake to 4,598,388 shares worth about $55.2 million.
• UiPath's stock recently traded at $10.99, with analysts setting an average price target of $13.83, reflecting a general "hold" rating from equity researchers.

Neuberger Berman Group LLC cut its holdings in UiPath, Inc. (NYSE:PATH - Free Report) by 1.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,481,954 shares of the company's stock after selling 44,394 shares during the period. Neuberger Berman Group LLC owned about 0.45% of UiPath worth $25,617,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of PATH. Versant Capital Management Inc raised its stake in shares of UiPath by 198.6% in the first quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock valued at $31,000 after buying an additional 1,970 shares during the period. CX Institutional bought a new stake in UiPath in the 1st quarter valued at about $36,000. True Wealth Design LLC lifted its holdings in UiPath by 18.4% during the fourth quarter. True Wealth Design LLC now owns 5,163 shares of the company's stock valued at $66,000 after purchasing an additional 801 shares during the last quarter. National Bank of Canada FI bought a new position in UiPath during the first quarter worth about $72,000. Finally, MRP Capital Investments LLC purchased a new position in shares of UiPath in the first quarter worth about $82,000. 62.50% of the stock is owned by institutional investors.

UiPath Price Performance

PATH stock traded up $0.25 during mid-day trading on Friday, hitting $10.98. 12,498,827 shares of the stock were exchanged, compared to its average volume of 14,116,685. The business has a fifty day moving average price of $12.22 and a 200 day moving average price of $12.19. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $15.93. The stock has a market capitalization of $5.87 billion, a price-to-earnings ratio of -91.49, a PEG ratio of 14.06 and a beta of 1.03.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative return on equity of 3.05% and a negative net margin of 4.65%. The firm had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. During the same quarter in the previous year, the company posted $0.13 earnings per share. The company's revenue was up 6.4% compared to the same quarter last year. As a group, equities analysts forecast that UiPath, Inc. will post -0.17 EPS for the current fiscal year.

Insider Transactions at UiPath

In other UiPath news, CEO Daniel Dines sold 9,988 shares of the company's stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $12.00, for a total transaction of $119,856.00. Following the completion of the sale, the chief executive officer directly owned 4,598,388 shares in the company, valued at $55,180,656. This represents a 0.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders have sold 831,310 shares of company stock worth $10,428,922 in the last ninety days. Corporate insiders own 23.19% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Morgan Stanley upped their price target on shares of UiPath from $12.00 to $15.00 and gave the company an "equal weight" rating in a research note on Monday, June 2nd. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a report on Friday, May 30th. Wall Street Zen cut shares of UiPath from a "strong-buy" rating to a "buy" rating in a report on Sunday, August 3rd. Barclays reissued an "equal weight" rating on shares of UiPath in a report on Friday, May 30th. Finally, Royal Bank Of Canada boosted their target price on shares of UiPath from $13.00 to $15.00 and gave the company a "sector perform" rating in a report on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, UiPath presently has a consensus rating of "Hold" and an average price target of $13.83.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.